Found: 68
Select item for more details and to access through your institution.
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.
- Published in:
- Protein & Cell, 2010, v. 1, n. 4, p. 342, doi. 10.1007/s13238-010-0054-6
- By:
- Publication type:
- Article
Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2013, v. 49, n. 2, p. 221, doi. 10.1165/rcmb.2012-0428OC
- By:
- Publication type:
- Article
SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00523-5
- By:
- Publication type:
- Article
Integrated Transcriptomics and Metabolomics Analysis Promotes the Understanding of Adventitious Root Formation in Eucommia ulmoides Oliver.
- Published in:
- Plants (2223-7747), 2024, v. 13, n. 1, p. 136, doi. 10.3390/plants13010136
- By:
- Publication type:
- Article
Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 10, p. 6578, doi. 10.1093/nar/gku260
- By:
- Publication type:
- Article
Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Complement Inhibition Alleviates Paraquat-Induced Acute Lung Injury.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2011, v. 45, n. 4, p. 834, doi. 10.1165/rcmb.2010-0444OC
- By:
- Publication type:
- Article
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
- Published in:
- Virology Journal, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-422X-10-266
- By:
- Publication type:
- Article
Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients.
- Published in:
- Virology Journal, 2010, v. 7, p. 299, doi. 10.1186/1743-422X-7-299
- By:
- Publication type:
- Article
An H5N1 M2e-based multiple antigenic peptidevaccine confers heterosubtypic protection fromlethal infection with pandemic 2009 H1N1 virus.
- Published in:
- Virology Journal, 2010, v. 7, p. 151, doi. 10.1186/1743-422X-7-151
- By:
- Publication type:
- Article
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.
- Published in:
- Virology Journal, 2010, v. 7, p. 1, doi. 10.1186/1743-422X-7-9
- By:
- Publication type:
- Article
A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.
- Published in:
- Molecules, 2019, v. 24, n. 6, p. 1134, doi. 10.3390/molecules24061134
- By:
- Publication type:
- Article
Characteristics of Oil Body Development and the Cloning and Expression Analysis of PDAT Genes in Eucommia ulmoides.
- Published in:
- Agronomy, 2022, v. 12, n. 9, p. 2197, doi. 10.3390/agronomy12092197
- By:
- Publication type:
- Article
Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 11, p. 1019, doi. 10.3390/v11111019
- By:
- Publication type:
- Article
MERS Coronavirus: An Emerging Zoonotic Virus.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 166, doi. 10.3390/v11020166
- By:
- Publication type:
- Article
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 1, p. 60, doi. 10.3390/v11010060
- By:
- Publication type:
- Article
Highly Pathogenic Avian Influenza A(H5N1) Mutants Transmissible by Air Are Susceptible to Human and Animal Neutralizing Antibodies.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 8, p. 1315, doi. 10.1093/infdis/jit323
- By:
- Publication type:
- Article
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00922-z
- By:
- Publication type:
- Article
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.
- Published in:
- Nature Communications, 2014, v. 5, n. 1, p. 3067, doi. 10.1038/ncomms4067
- By:
- Publication type:
- Article
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.
- Published in:
- Reviews in Medical Virology, 2016, v. 26, n. 4, p. 242, doi. 10.1002/rmv.1879
- By:
- Publication type:
- Article
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses.
- Published in:
- Reviews in Medical Virology, 2012, v. 22, n. 6, p. 412, doi. 10.1002/rmv.1729
- By:
- Publication type:
- Article
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02573-7
- By:
- Publication type:
- Article
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 605, doi. 10.3390/vaccines12060605
- By:
- Publication type:
- Article
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 481, doi. 10.3390/vaccines8030481
- By:
- Publication type:
- Article
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 251, doi. 10.3390/vaccines8020251
- By:
- Publication type:
- Article
Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 161, doi. 10.3390/vaccines7040161
- By:
- Publication type:
- Article
Research on the E-business Enterprise Employee Occupation Commitment and Career happiness based on Network Survey.
- Published in:
- RISTI: Iberian Journal on Information Systems & Technologies / Revista Ibérica de Sistemas e Tecnologias de Informação, 2016, n. E5, p. 360
- By:
- Publication type:
- Article
An Evolutionary Game Model of the Supply Decisions between GNPOs and Hospitals during a Public Health Emergency.
- Published in:
- Sustainability (2071-1050), 2022, v. 14, n. 3, p. 1156, doi. 10.3390/su14031156
- By:
- Publication type:
- Article
Structure-guided in vitro evolution of nanobodies targeting new viral variants.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1012600
- By:
- Publication type:
- Article
The spike protein of SARS-CoV — a target for vaccine and therapeutic development.
- Published in:
- Nature Reviews Microbiology, 2009, v. 7, n. 3, p. 226, doi. 10.1038/nrmicro2090
- By:
- Publication type:
- Article
The development of Nanosota-1 as antiSARS-CoV-2 nanobody drug candidates.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.64815
- By:
- Publication type:
- Article
Allocation strategy of medical supplies during a public health emergency: a tripartite evolutionary game perspective.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36000-y
- By:
- Publication type:
- Article
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 15672, doi. 10.1038/ncomms15672
- By:
- Publication type:
- Article
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13473, doi. 10.1038/ncomms13473
- By:
- Publication type:
- Article
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8223, doi. 10.1038/ncomms9223
- By:
- Publication type:
- Article
Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092987
- By:
- Publication type:
- Article
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0081587
- By:
- Publication type:
- Article
A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross- Protection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053568
- By:
- Publication type:
- Article
The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037019
- By:
- Publication type:
- Article
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016555
- By:
- Publication type:
- Article
INFLUENCES OF ALTRUISTIC MOTIVATION, SHARED VISION, AND PERCEIVED ACCESSIBILITY ON MICROCHARITY BEHAVIOR.
- Published in:
- Social Behavior & Personality: an international journal, 2014, v. 42, n. 10, p. 1639, doi. 10.2224/sbp.2014.42.10.1639
- By:
- Publication type:
- Article
IMPACT OF MOBILIZATION CONTEXT ON EMPLOYEES' DONATION INTENTIONS IN CHINA.
- Published in:
- Social Behavior & Personality: an international journal, 2014, v. 42, n. 1, p. 115, doi. 10.2224/sbp.2014.42.1.115
- By:
- Publication type:
- Article
PUBLIC SERVICE MOTIVATION OF PUBLIC- VERSUS PRIVATE-SECTOR EMPLOYEES IN A CHINESE CONTEXT.
- Published in:
- Social Behavior & Personality: an international journal, 2012, v. 40, n. 9, p. 1409, doi. 10.2224/sbp.2012.40.9.1409
- By:
- Publication type:
- Article
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00580-z
- By:
- Publication type:
- Article
Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection.
- Published in:
- Viruses (1999-4915), 2015, v. 7, n. 2, p. 798, doi. 10.3390/v7020798
- By:
- Publication type:
- Article
Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket.
- Published in:
- Viruses (1999-4915), 2013, v. 5, n. 1, p. 127, doi. 10.3390/v5010127
- By:
- Publication type:
- Article
A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses.
- Published in:
- BioScience Trends, 2013, v. 7, n. 3, p. 129, doi. 10.5582/bst.2013.v7.3.129
- By:
- Publication type:
- Article